, Tracking Stock Market Picks
Enter Symbol:
galena biopharma (GALE) [hlAlert]

down 27.31 %

galena biopharma (GALE) rated Buy with price target $3.50 by Needham

Posted on: Monday,  Mar 25, 2013  8:25 AM ET by Needham

Needham rated Buy galena biopharma (NASDAQ: GALE) on 03/25/2013, when the stock price was $2.05. Since
then, galena biopharma has lost 27.32% as of 01/21/2016's recent price of $1.49.
If you would have followed this Needham's recommendation on GALE, you would have lost 27.31% of your investment in 1032 days.

RXi Pharmaceuticals Corporation (RXi) is a discovery-stage biopharmaceutical company pursuing therapeutics based on ribonucleic acid interference (RNAi) for the treatment of human diseases. The Company is focused on internal research and development programs on certain inflammatory and metabolic diseases, and to pursue other therapeutic areas with potential partners. RXi commenced operations after CytRx Corporation contributed to the Company its portfolio of RNAi therapeutic assets, which consisted primarily of RNAi licenses and related intellectual property, and a nominal amount of equipment. As of December 31, 2008, the Company had not generated any revenues.

Needham & Company, LLC focuses on emerging growth companies in technology, biotechnology and life sciences. The firm's research goal is to service the needs of growth-oriented institutional clients. Needham & Company has established itself as a premier specialty investment bank providing timely and valuable analysis on companies that are under-covered by the majority of Wall Street firms.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/25/2013 8:25 AM Buy
2.05 3.50
as of 12/13/2013
1 Week down  -6.54 %
1 Month up  38.00 %
3 Months up  113.40 %
1 YTD up  101.95 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy